Retraction-validation of gene signatures that predict the response of breast cancer to neoadjuvant chemotherapy: A substudy of the EORTC 10994/BIG 00-01 clinical trial

The Lancet Oncology

Volumn 12, Issue 2, 2011, Pages 116-

  Bonnefoi, Hervé ^a   Potti, Anil ^a   Delorenzi, Mauro ^a   Mauriac, Louis ^a   Campone, Mario ^a   Tubiana Hulin, Michèle ^a   Petit, Thierry ^a   Rouanet, Philippe ^a   Jassem, Jacek ^a   Blot, Emmanuel ^a   Becette, Véronique ^a   Farmer, Pierre ^a   André, Sylvie ^a   Acharya, Chaitanya R ^a   Mukherjee, Sayan ^a   Cameron, David ^a   Bergh, Jonas ^a   Nevins, Joseph R ^a   Iggo, Richard D ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

[No Author keywords available]

Indexed keywords

LETTER; PRIORITY JOURNAL; RETRACTED ARTICLE;

EID: 79251528216     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(11)70011-0     Document Type: Letter

References (4)

1. Bonnefoi H, Potti A, Delorenzi M, et al. Validation of gene signatures that predict the response of breast cancer to neoadjuvant chemotherapy: a substudy of the EORTC 10994/BIG 00-01 clinical trial. Lancet Oncol 2007, 8:1071-1078.
2. Collingridge D Expression of concern-validation of gene signatures that predict the response of breast cancer to neoadjuvant chemotherapy: a substudy of the EORTC 10994/BIG 00-01 clinical trial. Lancet Oncol 2010, 11:813-814.
3. Potti A, Dressman HK, Bild A, et al. Genomic signatures to guide the use of chemotherapeutics. Nat Med 2006, 12:1294-1300.
4. Potti A, Dressman HK, Bild A, et al. Retraction: genomic signatures to guide the use of chemotherapeutics. Nat Med 2011, 17:135.